Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Study declares HRT not contraindicated for women previously treated for cervical cancer
November 10th, 2005
A recent study declares hormone replacement therapy is not contraindicated for women previously treated for cervical cancer. "The role of female hormones in estrogen-dependent cancers has been debated for years. This is particularly true of breast cancer," observed researchers from the United States. "Retrospective, case, and cohort control studies usually have suggested no influence," wrote W. T. Creasman. "The Women's Health Initiative study in 2002, a prospective double-blind study, noted an increased risk of breast cancer if estrogen-only arm of that study, a decreased (not significant) risk of breast cancer was noted. With this controversy, can...
Source: Women's Health Weekly (2005-11-10)
|
